Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo

NCT03365141 is registered in ClinicalTrials.gov with The Catholic University of Korea as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03365141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo
Lead sponsor
The Catholic University of Korea
Phase
Not applicable
Overall status
Unknown status
Start date
November 14, 2017
Completion date
September 15, 2018
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corticosteroid, intralesional injection, treatment, vitiligo